GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Institutional Ownership

Polarean Imaging (LSE:POLX) Institutional Ownership : 6.73% (As of May. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Polarean Imaging's institutional ownership is 6.73%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Polarean Imaging's Insider Ownership is 9.89%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Polarean Imaging's Float Percentage Of Total Shares Outstanding is 0.00%.


Polarean Imaging Institutional Ownership Historical Data

The historical data trend for Polarean Imaging's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Institutional Ownership Chart

Polarean Imaging Historical Data

The historical data trend for Polarean Imaging can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 8.97 8.88 8.25 7.50 6.97 6.95 6.95 6.75 6.73 6.73

Polarean Imaging Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines